Registry Trials

Expert Meetings

Overview

The primary purpose of registries has traditionally been to collect data to better understand long-term trends in specific populations. Data from registries hold great potential: they can help make clinical trials more efficient and less expensive and potentially bring new treatments to patients faster. 

To achieve this potential, stakeholders can use CTTI’s recommendations for registry trials to assess, develop, and evaluate registries for the support of clinical research and help meet expectations for FDA review of new products. 

Solutions

Search All

News

Case Study

    In Detail